Changes in cytoprotective signaling may influence cardiac aging, and underpin
sensitization to ischemic insult and desensitization to ‘anti-ischemic’
therapies. We tested whether age-dependent shifts in ischemia-reperfusion (I-R) tolerance
in murine and human myocardium are associated with reduced efficacies and coupling of
membrane, cytoplasmic and mitochondrial survival-signaling. Hormesis (exemplified in
ischemic preconditioning; IPC) and expression of proteins influencing
signaling/stress-resistance were also assessed in mice. Mouse hearts (18
vs. 2–4 mo) and human atrial tissue (75±2
vs. 55±2 yr) exhibited profound age-dependent reductions in I-R
tolerance. In mice aging negated cardioprotection via IPC, G-protein coupled receptor
(GPCR) agonism (opioid, A1 and A3 adenosine receptors) and distal
protein kinase C (PKC) activation (4 nM phorbol 12-myristate 13-acetate; PMA). In
contrast, p38-mitogen activated protein kinase (p38-MAPK) activation (1 μM
anisomycin), mitochondrial ATP-sensitive K+ channel (mKATP)
opening (50 μM diazoxide) and permeability transition pore (mPTP) inhibition (0.2
μM cyclosporin A) retained protective efficacies in older hearts (though failed to
eliminate I-R tolerance differences). A similar pattern of change in protective efficacies
was observed in human tissue. Murine hearts exhibited molecular changes consistent with
altered membrane control (reduced caveolin-3, cholesterol and caveolae), kinase signaling
(reduced p70 ribosomal s6 kinase; p70s6K) and stress-resistance (increased G-protein
receptor kinase 2, GRK2; glycogen synthase kinase 3β, GSK3β; and cytosolic
cytochrome c). In summary, myocardial I-R tolerance declines with age in
association with dysfunctional hormesis and transduction of survival signals from
GPCRs/PKC to mitochondrial effectors. Differential changes in proteins governing caveolar
and mitochondrial function may contribute to signal dysfunction and
stress-intolerance.